世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のヒト用ワクチン販売市場レポート 2022年


Global Human Vaccine Sales Market Report 2022

ワクチンとは、特定の疾患に対する能動的な獲得免疫を提供する生物学的製剤のことです。ワクチンは通常、病気を引き起こす微生物に類似した物質を含み、多くの場合、その微生物、その毒素、またはその表面タンパ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年9月16日 US$4,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ワクチンとは、特定の疾患に対する能動的な獲得免疫を提供する生物学的製剤のことです。ワクチンは通常、病気を引き起こす微生物に類似した物質を含み、多くの場合、その微生物、その毒素、またはその表面タンパク質の1つを弱めたもの、または殺したものから作られています。

市場の分析と洞察ヒト用ワクチンの世界市場
COVID-19の大流行により、世界のヒト用ワクチンの市場規模は2021年に3億1950万米ドルと推定され、レビュー期間中にCAGR4.6%で2028年までに3億1950万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にヒト用ワクチンの世界市場の%を占めたタイプ別は、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された%のCAGRで成長すると予測されます。一方、タイプ別セグメントは、この予測期間を通して%CAGRに変更されています。

中国では、ヒト用ワクチンの主要なプレーヤーは、CNBG、Kangtai、ChengDaバイオなどがあります。世界の上位3社で約65%のシェアを占めています。
最大の市場は華東で、シェアは約25%、次いで華南、華北で、いずれもシェアは約40%となっています。
製品別では、B型肝炎が最も大きなセグメントで、約15%のシェアを占めています。また、用途別では、「小児」が最も多く、次いで「成人」となっています。

ヒト用ワクチンの世界市場範囲と市場規模
ヒト用ワクチンの世界市場は、企業別、地域(国)別、タイプ別、用途別に分類されています。世界のHuman Vaccine市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント分析では、2017年から2028年までの地域(国)別、タイプ別、用途別の売上、収益、予測に焦点を当てます。

タイプ別セグメント
水痘(みずぼうそう
インフルエンザ
ポリオ
A型肝炎
狂犬病
BCG
B型肝炎
百日せき、ジフテリア、破傷風
肺炎球菌
ロタワクチン

用途別セグメント
成人
小児

地域別
米国
欧州
中国
日本
東南アジア
インド
その他の地域

会社別
CNBG
長生人寿
Zhifei
成大生物
康泰
シノバクバイオテック
ヒッセン
ウォルバックスバイオテクノロジー
GSK
サノフィ
ロンアン
ヌオチェン・バイオ
花蘭バイオ
天壇バイオ
長春白柯
アディミューン
中塩柯バイオテック
バーラト・バイオテック
バイエルン・ノルディック
サノフィパスツール
インディアン・イミュノロジカルズ
康師傅
河南大生物製剤
中科生物製剤
卓義バイオ


ページTOPに戻る


目次

1 Human Vaccine Market Overview
1.1 Human Vaccine Product Scope
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales by Type (2017 & 2021 & 2028)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application (2017 & 2021 & 2028)
1.3.2 Adults
1.3.3 Children
1.4 Human Vaccine Market Estimates and Forecasts (2017-2028)
1.4.1 Global Human Vaccine Market Size in Value Growth Rate (2017-2028)
1.4.2 Global Human Vaccine Market Size in Volume Growth Rate (2017-2028)
1.4.3 Global Human Vaccine Price Trends (2017-2028)
2 Human Vaccine Estimates and Forecasts by Region
2.1 Global Human Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2 Global Human Vaccine Retrospective Market Scenario by Region (2017-2022)
2.2.1 Global Human Vaccine Sales Market Share by Region (2017-2022)
2.2.2 Global Human Vaccine Revenue Market Share by Region (2017-2022)
2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2023-2028)
2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2023-2028)
2.3.2 Global Human Vaccine Revenue Forecast by Region (2023-2028)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Vaccine Estimates and Projections (2017-2028)
2.4.2 Europe Human Vaccine Estimates and Projections (2017-2028)
2.4.3 China Human Vaccine Estimates and Projections (2017-2028)
2.4.4 Japan Human Vaccine Estimates and Projections (2017-2028)
2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2017-2028)
2.4.6 India Human Vaccine Estimates and Projections (2017-2028)
3 Global Human Vaccine Competition Landscape by Players
3.1 Global Top Human Vaccine Players by Sales (2017-2022)
3.2 Global Top Human Vaccine Players by Revenue (2017-2022)
3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021)
3.4 Global Human Vaccine Average Price by Company (2017-2022)
3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Vaccine Market Size by Type
4.1 Global Human Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Human Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Human Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Global Human Vaccine Price by Type (2017-2022)
4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Human Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Global Human Vaccine Price Forecast by Type (2023-2028)
5 Global Human Vaccine Market Size by Application
5.1 Global Human Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Human Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Human Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Global Human Vaccine Price by Application (2017-2022)
5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Human Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Global Human Vaccine Price Forecast by Application (2023-2028)
6 United States Human Vaccine Market Facts & Figures
6.1 United States Human Vaccine Sales by Company
6.1.1 United States Human Vaccine Sales by Company (2017-2022)
6.1.2 United States Human Vaccine Revenue by Company (2017-2022)
6.2 United States Human Vaccine Sales Breakdown by Type
6.2.1 United States Human Vaccine Sales Breakdown by Type (2017-2022)
6.2.2 United States Human Vaccine Sales Breakdown by Type (2023-2028)
6.3 United States Human Vaccine Sales Breakdown by Application
6.3.1 United States Human Vaccine Sales Breakdown by Application (2017-2022)
6.3.2 United States Human Vaccine Sales Breakdown by Application (2023-2028)
7 Europe Human Vaccine Market Facts & Figures
7.1 Europe Human Vaccine Sales by Company
7.1.1 Europe Human Vaccine Sales by Company (2017-2022)
7.1.2 Europe Human Vaccine Revenue by Company (2017-2022)
7.2 Europe Human Vaccine Sales Breakdown by Type
7.2.1 Europe Human Vaccine Sales Breakdown by Type (2017-2022)
7.2.2 Europe Human Vaccine Sales Breakdown by Type (2023-2028)
7.3 Europe Human Vaccine Sales Breakdown by Application
7.3.1 Europe Human Vaccine Sales Breakdown by Application (2017-2022)
7.3.2 Europe Human Vaccine Sales Breakdown by Application (2023-2028)
8 China Human Vaccine Market Facts & Figures
8.1 China Human Vaccine Sales by Company
8.1.1 China Human Vaccine Sales by Company (2017-2022)
8.1.2 China Human Vaccine Revenue by Company (2017-2022)
8.2 China Human Vaccine Sales Breakdown by Type
8.2.1 China Human Vaccine Sales Breakdown by Type (2017-2022)
8.2.2 China Human Vaccine Sales Breakdown by Type (2023-2028)
8.3 China Human Vaccine Sales Breakdown by Application
8.3.1 China Human Vaccine Sales Breakdown by Application (2017-2022)
8.3.2 China Human Vaccine Sales Breakdown by Application (2023-2028)
9 Japan Human Vaccine Market Facts & Figures
9.1 Japan Human Vaccine Sales by Company
9.1.1 Japan Human Vaccine Sales by Company (2017-2022)
9.1.2 Japan Human Vaccine Revenue by Company (2017-2022)
9.2 Japan Human Vaccine Sales Breakdown by Type
9.2.1 Japan Human Vaccine Sales Breakdown by Type (2017-2022)
9.2.2 Japan Human Vaccine Sales Breakdown by Type (2023-2028)
9.3 Japan Human Vaccine Sales Breakdown by Application
9.3.1 Japan Human Vaccine Sales Breakdown by Application (2017-2022)
9.3.2 Japan Human Vaccine Sales Breakdown by Application (2023-2028)
10 Southeast Asia Human Vaccine Market Facts & Figures
10.1 Southeast Asia Human Vaccine Sales by Company
10.1.1 Southeast Asia Human Vaccine Sales by Company (2017-2022)
10.1.2 Southeast Asia Human Vaccine Revenue by Company (2017-2022)
10.2 Southeast Asia Human Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Human Vaccine Sales Breakdown by Type (2017-2022)
10.2.2 Southeast Asia Human Vaccine Sales Breakdown by Type (2023-2028)
10.3 Southeast Asia Human Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia Human Vaccine Sales Breakdown by Application (2017-2022)
10.3.2 Southeast Asia Human Vaccine Sales Breakdown by Application (2023-2028)
11 India Human Vaccine Market Facts & Figures
11.1 India Human Vaccine Sales by Company
11.1.1 India Human Vaccine Sales by Company (2017-2022)
11.1.2 India Human Vaccine Revenue by Company (2017-2022)
11.2 India Human Vaccine Sales Breakdown by Type
11.2.1 India Human Vaccine Sales Breakdown by Type (2017-2022)
11.2.2 India Human Vaccine Sales Breakdown by Type (2023-2028)
11.3 India Human Vaccine Sales Breakdown by Application
11.3.1 India Human Vaccine Sales Breakdown by Application (2017-2022)
11.3.2 India Human Vaccine Sales Breakdown by Application (2023-2028)
12 Company Profiles and Key Figures in Human Vaccine Business
12.1 CNBG
12.1.1 CNBG Corporation Information
12.1.2 CNBG Business Overview
12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.1.4 CNBG Human Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 Changsheng Life
12.2.1 Changsheng Life Corporation Information
12.2.2 Changsheng Life Business Overview
12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.2.4 Changsheng Life Human Vaccine Products Offered
12.2.5 Changsheng Life Recent Development
12.3 Zhifei
12.3.1 Zhifei Corporation Information
12.3.2 Zhifei Business Overview
12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.3.4 Zhifei Human Vaccine Products Offered
12.3.5 Zhifei Recent Development
12.4 ChengDa Bio
12.4.1 ChengDa Bio Corporation Information
12.4.2 ChengDa Bio Business Overview
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.4.4 ChengDa Bio Human Vaccine Products Offered
12.4.5 ChengDa Bio Recent Development
12.5 Kangtai
12.5.1 Kangtai Corporation Information
12.5.2 Kangtai Business Overview
12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.5.4 Kangtai Human Vaccine Products Offered
12.5.5 Kangtai Recent Development
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Corporation Information
12.6.2 SINOVAC BIOTECH Business Overview
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
12.6.5 SINOVAC BIOTECH Recent Development
12.7 Hissen
12.7.1 Hissen Corporation Information
12.7.2 Hissen Business Overview
12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.7.4 Hissen Human Vaccine Products Offered
12.7.5 Hissen Recent Development
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Corporation Information
12.8.2 Walvax Biotechnology Business Overview
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.8.4 Walvax Biotechnology Human Vaccine Products Offered
12.8.5 Walvax Biotechnology Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Business Overview
12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.9.4 GSK Human Vaccine Products Offered
12.9.5 GSK Recent Development
12.10 SANOFI
12.10.1 SANOFI Corporation Information
12.10.2 SANOFI Business Overview
12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.10.4 SANOFI Human Vaccine Products Offered
12.10.5 SANOFI Recent Development
12.11 Rong An
12.11.1 Rong An Corporation Information
12.11.2 Rong An Business Overview
12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.11.4 Rong An Human Vaccine Products Offered
12.11.5 Rong An Recent Development
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Corporation Information
12.12.2 NuoCheng Bio Business Overview
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.12.4 NuoCheng Bio Human Vaccine Products Offered
12.12.5 NuoCheng Bio Recent Development
12.13 Hualan Bio
12.13.1 Hualan Bio Corporation Information
12.13.2 Hualan Bio Business Overview
12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.13.4 Hualan Bio Human Vaccine Products Offered
12.13.5 Hualan Bio Recent Development
12.14 Tiantan biological
12.14.1 Tiantan biological Corporation Information
12.14.2 Tiantan biological Business Overview
12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.14.4 Tiantan biological Human Vaccine Products Offered
12.14.5 Tiantan biological Recent Development
12.15 Changchun Baike
12.15.1 Changchun Baike Corporation Information
12.15.2 Changchun Baike Business Overview
12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.15.4 Changchun Baike Human Vaccine Products Offered
12.15.5 Changchun Baike Recent Development
12.16 Adimmune
12.16.1 Adimmune Corporation Information
12.16.2 Adimmune Business Overview
12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.16.4 Adimmune Human Vaccine Products Offered
12.16.5 Adimmune Recent Development
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Corporation Information
12.17.2 Zhongyianke Biotech Business Overview
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.17.4 Zhongyianke Biotech Human Vaccine Products Offered
12.17.5 Zhongyianke Biotech Recent Development
12.18 Bharat Biotech
12.18.1 Bharat Biotech Corporation Information
12.18.2 Bharat Biotech Business Overview
12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.18.4 Bharat Biotech Human Vaccine Products Offered
12.18.5 Bharat Biotech Recent Development
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Corporation Information
12.19.2 Bavarian Nordic Business Overview
12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.19.4 Bavarian Nordic Human Vaccine Products Offered
12.19.5 Bavarian Nordic Recent Development
12.20 Sanofi-Pasteur
12.20.1 Sanofi-Pasteur Corporation Information
12.20.2 Sanofi-Pasteur Business Overview
12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.20.4 Sanofi-Pasteur Human Vaccine Products Offered
12.20.5 Sanofi-Pasteur Recent Development
12.21 Indian Immunologicals
12.21.1 Indian Immunologicals Corporation Information
12.21.2 Indian Immunologicals Business Overview
12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.21.4 Indian Immunologicals Human Vaccine Products Offered
12.21.5 Indian Immunologicals Recent Development
12.22 KANGH
12.22.1 KANGH Corporation Information
12.22.2 KANGH Business Overview
12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.22.4 KANGH Human Vaccine Products Offered
12.22.5 KANGH Recent Development
12.23 Henan Grand Biopharma
12.23.1 Henan Grand Biopharma Corporation Information
12.23.2 Henan Grand Biopharma Business Overview
12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.23.4 Henan Grand Biopharma Human Vaccine Products Offered
12.23.5 Henan Grand Biopharma Recent Development
12.24 ZhongKe Biopharm
12.24.1 ZhongKe Biopharm Corporation Information
12.24.2 ZhongKe Biopharm Business Overview
12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.24.4 ZhongKe Biopharm Human Vaccine Products Offered
12.24.5 ZhongKe Biopharm Recent Development
12.25 Zhuoyi Biological
12.25.1 Zhuoyi Biological Corporation Information
12.25.2 Zhuoyi Biological Business Overview
12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.25.4 Zhuoyi Biological Human Vaccine Products Offered
12.25.5 Zhuoyi Biological Recent Development
13 Human Vaccine Manufacturing Cost Analysis
13.1 Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Vaccine
13.4 Human Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Vaccine Distributors List
14.3 Human Vaccine Customers
15 Market Dynamics
15.1 Human Vaccine Industry Trends
15.2 Human Vaccine Market Drivers
15.3 Human Vaccine Market Challenges
15.4 Human Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

 

ページTOPに戻る


 

Summary

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

Market Analysis and Insights: Global Human Vaccine Market
Due to the COVID-19 pandemic, the global Human Vaccine market size is estimated to be worth US$ 31950 million in 2021 and is forecast to a readjusted size of US$ 31950 million by 2028 with a CAGR of 4.6% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Human Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

Global Human Vaccine Scope and Market Size
The global Human Vaccine market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Human Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine

Segment by Application
Adults
Children

By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions

By Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological



ページTOPに戻る


Table of Contents

1 Human Vaccine Market Overview
1.1 Human Vaccine Product Scope
1.2 Human Vaccine Segment by Type
1.2.1 Global Human Vaccine Sales by Type (2017 & 2021 & 2028)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Human Vaccine Segment by Application
1.3.1 Global Human Vaccine Sales Comparison by Application (2017 & 2021 & 2028)
1.3.2 Adults
1.3.3 Children
1.4 Human Vaccine Market Estimates and Forecasts (2017-2028)
1.4.1 Global Human Vaccine Market Size in Value Growth Rate (2017-2028)
1.4.2 Global Human Vaccine Market Size in Volume Growth Rate (2017-2028)
1.4.3 Global Human Vaccine Price Trends (2017-2028)
2 Human Vaccine Estimates and Forecasts by Region
2.1 Global Human Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2 Global Human Vaccine Retrospective Market Scenario by Region (2017-2022)
2.2.1 Global Human Vaccine Sales Market Share by Region (2017-2022)
2.2.2 Global Human Vaccine Revenue Market Share by Region (2017-2022)
2.3 Global Human Vaccine Market Estimates and Forecasts by Region (2023-2028)
2.3.1 Global Human Vaccine Sales Estimates and Forecasts by Region (2023-2028)
2.3.2 Global Human Vaccine Revenue Forecast by Region (2023-2028)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Vaccine Estimates and Projections (2017-2028)
2.4.2 Europe Human Vaccine Estimates and Projections (2017-2028)
2.4.3 China Human Vaccine Estimates and Projections (2017-2028)
2.4.4 Japan Human Vaccine Estimates and Projections (2017-2028)
2.4.5 Southeast Asia Human Vaccine Estimates and Projections (2017-2028)
2.4.6 India Human Vaccine Estimates and Projections (2017-2028)
3 Global Human Vaccine Competition Landscape by Players
3.1 Global Top Human Vaccine Players by Sales (2017-2022)
3.2 Global Top Human Vaccine Players by Revenue (2017-2022)
3.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021)
3.4 Global Human Vaccine Average Price by Company (2017-2022)
3.5 Manufacturers Human Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Vaccine Market Size by Type
4.1 Global Human Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Human Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Human Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Global Human Vaccine Price by Type (2017-2022)
4.2 Global Human Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Human Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Global Human Vaccine Price Forecast by Type (2023-2028)
5 Global Human Vaccine Market Size by Application
5.1 Global Human Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Human Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Human Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Global Human Vaccine Price by Application (2017-2022)
5.2 Global Human Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Human Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Global Human Vaccine Price Forecast by Application (2023-2028)
6 United States Human Vaccine Market Facts & Figures
6.1 United States Human Vaccine Sales by Company
6.1.1 United States Human Vaccine Sales by Company (2017-2022)
6.1.2 United States Human Vaccine Revenue by Company (2017-2022)
6.2 United States Human Vaccine Sales Breakdown by Type
6.2.1 United States Human Vaccine Sales Breakdown by Type (2017-2022)
6.2.2 United States Human Vaccine Sales Breakdown by Type (2023-2028)
6.3 United States Human Vaccine Sales Breakdown by Application
6.3.1 United States Human Vaccine Sales Breakdown by Application (2017-2022)
6.3.2 United States Human Vaccine Sales Breakdown by Application (2023-2028)
7 Europe Human Vaccine Market Facts & Figures
7.1 Europe Human Vaccine Sales by Company
7.1.1 Europe Human Vaccine Sales by Company (2017-2022)
7.1.2 Europe Human Vaccine Revenue by Company (2017-2022)
7.2 Europe Human Vaccine Sales Breakdown by Type
7.2.1 Europe Human Vaccine Sales Breakdown by Type (2017-2022)
7.2.2 Europe Human Vaccine Sales Breakdown by Type (2023-2028)
7.3 Europe Human Vaccine Sales Breakdown by Application
7.3.1 Europe Human Vaccine Sales Breakdown by Application (2017-2022)
7.3.2 Europe Human Vaccine Sales Breakdown by Application (2023-2028)
8 China Human Vaccine Market Facts & Figures
8.1 China Human Vaccine Sales by Company
8.1.1 China Human Vaccine Sales by Company (2017-2022)
8.1.2 China Human Vaccine Revenue by Company (2017-2022)
8.2 China Human Vaccine Sales Breakdown by Type
8.2.1 China Human Vaccine Sales Breakdown by Type (2017-2022)
8.2.2 China Human Vaccine Sales Breakdown by Type (2023-2028)
8.3 China Human Vaccine Sales Breakdown by Application
8.3.1 China Human Vaccine Sales Breakdown by Application (2017-2022)
8.3.2 China Human Vaccine Sales Breakdown by Application (2023-2028)
9 Japan Human Vaccine Market Facts & Figures
9.1 Japan Human Vaccine Sales by Company
9.1.1 Japan Human Vaccine Sales by Company (2017-2022)
9.1.2 Japan Human Vaccine Revenue by Company (2017-2022)
9.2 Japan Human Vaccine Sales Breakdown by Type
9.2.1 Japan Human Vaccine Sales Breakdown by Type (2017-2022)
9.2.2 Japan Human Vaccine Sales Breakdown by Type (2023-2028)
9.3 Japan Human Vaccine Sales Breakdown by Application
9.3.1 Japan Human Vaccine Sales Breakdown by Application (2017-2022)
9.3.2 Japan Human Vaccine Sales Breakdown by Application (2023-2028)
10 Southeast Asia Human Vaccine Market Facts & Figures
10.1 Southeast Asia Human Vaccine Sales by Company
10.1.1 Southeast Asia Human Vaccine Sales by Company (2017-2022)
10.1.2 Southeast Asia Human Vaccine Revenue by Company (2017-2022)
10.2 Southeast Asia Human Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Human Vaccine Sales Breakdown by Type (2017-2022)
10.2.2 Southeast Asia Human Vaccine Sales Breakdown by Type (2023-2028)
10.3 Southeast Asia Human Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia Human Vaccine Sales Breakdown by Application (2017-2022)
10.3.2 Southeast Asia Human Vaccine Sales Breakdown by Application (2023-2028)
11 India Human Vaccine Market Facts & Figures
11.1 India Human Vaccine Sales by Company
11.1.1 India Human Vaccine Sales by Company (2017-2022)
11.1.2 India Human Vaccine Revenue by Company (2017-2022)
11.2 India Human Vaccine Sales Breakdown by Type
11.2.1 India Human Vaccine Sales Breakdown by Type (2017-2022)
11.2.2 India Human Vaccine Sales Breakdown by Type (2023-2028)
11.3 India Human Vaccine Sales Breakdown by Application
11.3.1 India Human Vaccine Sales Breakdown by Application (2017-2022)
11.3.2 India Human Vaccine Sales Breakdown by Application (2023-2028)
12 Company Profiles and Key Figures in Human Vaccine Business
12.1 CNBG
12.1.1 CNBG Corporation Information
12.1.2 CNBG Business Overview
12.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.1.4 CNBG Human Vaccine Products Offered
12.1.5 CNBG Recent Development
12.2 Changsheng Life
12.2.1 Changsheng Life Corporation Information
12.2.2 Changsheng Life Business Overview
12.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.2.4 Changsheng Life Human Vaccine Products Offered
12.2.5 Changsheng Life Recent Development
12.3 Zhifei
12.3.1 Zhifei Corporation Information
12.3.2 Zhifei Business Overview
12.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.3.4 Zhifei Human Vaccine Products Offered
12.3.5 Zhifei Recent Development
12.4 ChengDa Bio
12.4.1 ChengDa Bio Corporation Information
12.4.2 ChengDa Bio Business Overview
12.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.4.4 ChengDa Bio Human Vaccine Products Offered
12.4.5 ChengDa Bio Recent Development
12.5 Kangtai
12.5.1 Kangtai Corporation Information
12.5.2 Kangtai Business Overview
12.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.5.4 Kangtai Human Vaccine Products Offered
12.5.5 Kangtai Recent Development
12.6 SINOVAC BIOTECH
12.6.1 SINOVAC BIOTECH Corporation Information
12.6.2 SINOVAC BIOTECH Business Overview
12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
12.6.5 SINOVAC BIOTECH Recent Development
12.7 Hissen
12.7.1 Hissen Corporation Information
12.7.2 Hissen Business Overview
12.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.7.4 Hissen Human Vaccine Products Offered
12.7.5 Hissen Recent Development
12.8 Walvax Biotechnology
12.8.1 Walvax Biotechnology Corporation Information
12.8.2 Walvax Biotechnology Business Overview
12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.8.4 Walvax Biotechnology Human Vaccine Products Offered
12.8.5 Walvax Biotechnology Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Business Overview
12.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.9.4 GSK Human Vaccine Products Offered
12.9.5 GSK Recent Development
12.10 SANOFI
12.10.1 SANOFI Corporation Information
12.10.2 SANOFI Business Overview
12.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.10.4 SANOFI Human Vaccine Products Offered
12.10.5 SANOFI Recent Development
12.11 Rong An
12.11.1 Rong An Corporation Information
12.11.2 Rong An Business Overview
12.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.11.4 Rong An Human Vaccine Products Offered
12.11.5 Rong An Recent Development
12.12 NuoCheng Bio
12.12.1 NuoCheng Bio Corporation Information
12.12.2 NuoCheng Bio Business Overview
12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.12.4 NuoCheng Bio Human Vaccine Products Offered
12.12.5 NuoCheng Bio Recent Development
12.13 Hualan Bio
12.13.1 Hualan Bio Corporation Information
12.13.2 Hualan Bio Business Overview
12.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.13.4 Hualan Bio Human Vaccine Products Offered
12.13.5 Hualan Bio Recent Development
12.14 Tiantan biological
12.14.1 Tiantan biological Corporation Information
12.14.2 Tiantan biological Business Overview
12.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.14.4 Tiantan biological Human Vaccine Products Offered
12.14.5 Tiantan biological Recent Development
12.15 Changchun Baike
12.15.1 Changchun Baike Corporation Information
12.15.2 Changchun Baike Business Overview
12.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.15.4 Changchun Baike Human Vaccine Products Offered
12.15.5 Changchun Baike Recent Development
12.16 Adimmune
12.16.1 Adimmune Corporation Information
12.16.2 Adimmune Business Overview
12.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.16.4 Adimmune Human Vaccine Products Offered
12.16.5 Adimmune Recent Development
12.17 Zhongyianke Biotech
12.17.1 Zhongyianke Biotech Corporation Information
12.17.2 Zhongyianke Biotech Business Overview
12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.17.4 Zhongyianke Biotech Human Vaccine Products Offered
12.17.5 Zhongyianke Biotech Recent Development
12.18 Bharat Biotech
12.18.1 Bharat Biotech Corporation Information
12.18.2 Bharat Biotech Business Overview
12.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.18.4 Bharat Biotech Human Vaccine Products Offered
12.18.5 Bharat Biotech Recent Development
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Corporation Information
12.19.2 Bavarian Nordic Business Overview
12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.19.4 Bavarian Nordic Human Vaccine Products Offered
12.19.5 Bavarian Nordic Recent Development
12.20 Sanofi-Pasteur
12.20.1 Sanofi-Pasteur Corporation Information
12.20.2 Sanofi-Pasteur Business Overview
12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.20.4 Sanofi-Pasteur Human Vaccine Products Offered
12.20.5 Sanofi-Pasteur Recent Development
12.21 Indian Immunologicals
12.21.1 Indian Immunologicals Corporation Information
12.21.2 Indian Immunologicals Business Overview
12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.21.4 Indian Immunologicals Human Vaccine Products Offered
12.21.5 Indian Immunologicals Recent Development
12.22 KANGH
12.22.1 KANGH Corporation Information
12.22.2 KANGH Business Overview
12.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.22.4 KANGH Human Vaccine Products Offered
12.22.5 KANGH Recent Development
12.23 Henan Grand Biopharma
12.23.1 Henan Grand Biopharma Corporation Information
12.23.2 Henan Grand Biopharma Business Overview
12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.23.4 Henan Grand Biopharma Human Vaccine Products Offered
12.23.5 Henan Grand Biopharma Recent Development
12.24 ZhongKe Biopharm
12.24.1 ZhongKe Biopharm Corporation Information
12.24.2 ZhongKe Biopharm Business Overview
12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.24.4 ZhongKe Biopharm Human Vaccine Products Offered
12.24.5 ZhongKe Biopharm Recent Development
12.25 Zhuoyi Biological
12.25.1 Zhuoyi Biological Corporation Information
12.25.2 Zhuoyi Biological Business Overview
12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
12.25.4 Zhuoyi Biological Human Vaccine Products Offered
12.25.5 Zhuoyi Biological Recent Development
13 Human Vaccine Manufacturing Cost Analysis
13.1 Human Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Vaccine
13.4 Human Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Vaccine Distributors List
14.3 Human Vaccine Customers
15 Market Dynamics
15.1 Human Vaccine Industry Trends
15.2 Human Vaccine Market Drivers
15.3 Human Vaccine Market Challenges
15.4 Human Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(抗生物薬)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る